Author: Norris Alan
Publisher: Informa Healthcare
ISSN: 1354-3784
Source: Expert Opinion on Investigational Drugs, Vol.13, Iss.7, 2004-07, pp. : 739-741
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Mast Cells as Targets of Pimecrolimus
Current Pharmaceutical Design, Vol. 17, Iss. 34, 2011-11 ,pp. :
Targeting CD44 in mast cell regulation
Expert Opinion on Therapeutic Targets, Vol. 14, Iss. 1, 2010-01 ,pp. :